Status:

COMPLETED

Effects of Different Centrifuged Platelet Concentrates on Bone Remodelling Around Dental Implants

Lead Sponsor:

Muhammet Atilgan

Collaborating Sponsors:

Mustafa Kemal University

Conditions:

Edentulous Jaw

Bone Loss, Alveolar

Eligibility:

All Genders

21-79 years

Phase:

NA

Brief Summary

Platelet concentrates obtained from blood have been used as regenerative biomaterials in periodontal surgery. Along with the migration and proliferation of osteogenic cells, platelets accelerate bone ...

Detailed Description

This study was conducted in Periodontology clinics. The study protocol was approved by the Hatay Mustafa Kemal University Human Ethics Committee before the initiation of the study (approval number:). ...

Eligibility Criteria

Inclusion

  • Above 18 years of age
  • Symmetrical edentulous areas in the mandible
  • Sufficient bone width and height permitting ideal dental implant placement
  • Individuals who do not smoke
  • At least 2 mm of keratinized gingiva width and 3 mm soft tissue thickness at the implant site

Exclusion

  • Patients with systemic disorders, including diabetes mellitus, metabolic bone disease, rheumatoid arthritis, mucocutaneous disorders, immunological disorders, hepatitis, or HIV
  • Individuals who were on antibiotics, anti-inflammatory agents, corticosteroids, immunosuppressants, anticoagulants, or hormonal contraceptives for any reason, at least 6 months prior to the procedure, and those who were on bisphosphonates at that time or previously.
  • Individuals with any pathology or defects at the implant site.
  • History augmentation at the implant site.
  • Individuals with severe periodontal disease and poor oral hygiene.
  • Severe caries or endodontic lesions in teeth adjacent to the implant.
  • Those who use intraoral orthodontic or prosthetic appliances that make plaque control difficult.
  • Pregnant and lactating individuals.

Key Trial Info

Start Date :

October 3 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 20 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04851002

Start Date

October 3 2019

End Date

March 20 2021

Last Update

April 20 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mustafa Kemal University

Hatay, Turkey (Türkiye), 31060